Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Precision BioSciences stock

Learn how to easily invest in Precision BioSciences stock.

Precision BioSciences Inc is a biotechnology business based in the US. Precision BioSciences shares (DTIL) are listed on the NASDAQ and all prices are listed in US Dollars. Precision BioSciences employs 192 staff and has a trailing 12-month revenue of around $37.5 million.

How to buy shares in Precision BioSciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DTIL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Precision BioSciences stock price (NASDAQ: DTIL)

Use our graph to track the performance of DTIL stocks over time.

Precision BioSciences shares at a glance

Information last updated 2022-10-03.
Latest market close$1.40
52-week range$1.11 - $11.41
50-day moving average $1.59
200-day moving average $3.00
Wall St. target price$8.22
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.67

Buy Precision BioSciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Precision BioSciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Precision BioSciences price performance over time

Historical closes compared with the close of $1.4 from 2022-10-03

1 week (2022-09-27) 11.11%
1 month (2022-09-02) -10.83%
3 months (2022-07-01) -8.50%
6 months (2022-03-31) -54.55%
1 year (2021-10-04) -87.21%
2 years (2020-10-02) -76.59%
3 years (2019-10-04) 7.56
5 years (2017-09-30) N/A

Precision BioSciences financials

Revenue TTM $37.5 million
Gross profit TTM $115.5 million
Return on assets TTM -23.53%
Return on equity TTM -91.14%
Profit margin -247.31%
Book value $0.93
Market capitalisation $144.1 million

TTM: trailing 12 months

Precision BioSciences share dividends

We're not expecting Precision BioSciences to pay a dividend over the next 12 months.

Precision BioSciences share price volatility

Over the last 12 months, Precision BioSciences's shares have ranged in value from as little as $1.11 up to $11.41. A popular way to gauge a stock's volatility is its "beta".

DTIL.US volatility(beta: 1.47)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precision BioSciences's is 1.4741. This would suggest that Precision BioSciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Precision BioSciences overview

Precision BioSciences, Inc. , a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific type of immune cell is genetically engineered to recognize and kill cancer cells; PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with R/R NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the risk of chromosome abnormalities; and PBCAR269A, an investigational allogeneic CAR T immunotherapy targeting BCMA for the treatment of R/R multiple myeloma. The company has development and commercial license agreement with Les Laboratoires Servier to develop allogeneic chimeric antigen receptor T cell therapies for antigen targets, hematological cancer targets beyond CD19, and solid tumor targets; Tiziana Life Sciences to evaluate foralumab, a fully human anti-CD3 monoclonal antibody as a lymphodepleting agent for the potential treatment of cancers; and iECURE, Inc. to develop ARCUS-based gene editing therapies. Precision BioSciences, Inc.

Frequently asked questions

What percentage of Precision BioSciences is owned by insiders or institutions?
Currently 17.049% of Precision BioSciences shares are held by insiders and 53.426% by institutions.
How many people work for Precision BioSciences?
Latest data suggests 192 work at Precision BioSciences.
When does the fiscal year end for Precision BioSciences?
Precision BioSciences's fiscal year ends in December.
Where is Precision BioSciences based?
Precision BioSciences's address is: 302 East Pettigrew Street, Durham, NC, United States, 27701
What is Precision BioSciences's ISIN number?
Precision BioSciences's international securities identification number is: US74019P1084
What is Precision BioSciences's CUSIP number?
Precision BioSciences's Committee on Uniform Securities Identification Procedures number is: 74019P108

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site